ArticleRespirology (Carlton, Vic.)2020

Efficacy and tolerance of immune checkpoint inhibitors for non-small cell lung cancer patients with interstitial lung disease.

Kinnosuke Matsumoto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.